These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11154227)

  • 1. Illegitimate switch recombinations are present in approximately half of primary myeloma tumors, but do not relate to known prognostic indicators or survival.
    Ho PJ; Brown RD; Pelka GJ; Basten A; Gibson J; Joshua DE
    Blood; 2001 Jan; 97(2):490-5. PubMed ID: 11154227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma.
    Bergsagel PL; Chesi M; Nardini E; Brents LA; Kirby SL; Kuehl WM
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13931-6. PubMed ID: 8943038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma.
    Chesi M; Kuehl WM; Bergsagel PL
    Ann Oncol; 2000; 11 Suppl 1():131-5. PubMed ID: 10707795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic characterization of the chromosomal breakpoints of t(4;14) of multiple myeloma suggests more than one possible aetiological mechanism.
    Fenton JA; Pratt G; Rawstron AC; Sibley K; Rothwell D; Yates Z; Dring A; Richards SJ; Ashcroft AJ; Davies FE; Owen RG; Child JA; Morgan GJ
    Oncogene; 2003 Feb; 22(7):1103-13. PubMed ID: 12592397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines.
    Chesi M; Bergsagel PL; Brents LA; Smith CM; Gerhard DS; Kuehl WM
    Blood; 1996 Jul; 88(2):674-81. PubMed ID: 8695815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel chromosomal translocation t(4; 14)(p16.3; q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene.
    Richelda R; Ronchetti D; Baldini L; Cro L; Viggiano L; Marzella R; Rocchi M; Otsuki T; Lombardi L; Maiolo AT; Neri A
    Blood; 1997 Nov; 90(10):4062-70. PubMed ID: 9354676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Light-chain only multiple myeloma is due to the absence of functional (productive) rearrangement of the IgH gene at the DNA level.
    Magrangeas F; Cormier ML; Descamps G; Gouy N; Lodé L; Mellerin MP; Harousseau JL; Bataille R; Minvielle S; Avet-Loiseau H
    Blood; 2004 May; 103(10):3869-75. PubMed ID: 14715636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing primary and secondary translocations in multiple myeloma.
    Gabrea A; Leif Bergsagel P; Michael Kuehl W
    DNA Repair (Amst); 2006 Sep; 5(9-10):1225-33. PubMed ID: 16829212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma.
    Shaughnessy J; Gabrea A; Qi Y; Brents L; Zhan F; Tian E; Sawyer J; Barlogie B; Bergsagel PL; Kuehl M
    Blood; 2001 Jul; 98(1):217-23. PubMed ID: 11418483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgH translocations in multiple myeloma: a nearly universal event that rarely involves c-myc.
    Bergsagel PL; Nardini E; Brents L; Chesi M; Kuehl WM
    Curr Top Microbiol Immunol; 1997; 224():283-7. PubMed ID: 9308253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple myeloma: illegitimate switch recombinations and their relation to chromosomal translocations.
    Schmidt HH
    Blood; 2002 Apr; 99(8):3072-3; author reply 3073-4. PubMed ID: 11949632
    [No Abstract]   [Full Text] [Related]  

  • 12. Translocation of an antibody transgene requires AID and occurs by interchromosomal switching to all switch regions except the mu switch region.
    Shansab M; Eccleston JM; Selsing E
    Eur J Immunol; 2011 May; 41(5):1456-64. PubMed ID: 21469111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies.
    Avet-Loiseau H; Li JY; Facon T; Brigaudeau C; Morineau N; Maloisel F; Rapp MJ; Talmant P; Trimoreau F; Jaccard A; Harousseau JL; Bataille R
    Cancer Res; 1998 Dec; 58(24):5640-5. PubMed ID: 9865713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Close relation between 14q32/IGH translocations and chromosome 13 abnormalities in multiple myeloma: a high incidence of 11q13/CCND1 and 16q23/MAF.
    Takimoto M; Ogawa K; Kato Y; Saito T; Suzuki T; Irei M; Shibuya Y; Suzuki Y; Kato M; Inoue Y; Takahashi M; Sugimori H; Miura I
    Int J Hematol; 2008 Apr; 87(3):260-5. PubMed ID: 18274833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome translocations in multiple myeloma.
    Bergsagel PL; Kuehl WM
    Oncogene; 2001 Sep; 20(40):5611-22. PubMed ID: 11607813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell.
    Gabrea A; Bergsagel PL; Chesi M; Shou Y; Kuehl WM
    Mol Cell; 1999 Jan; 3(1):119-23. PubMed ID: 10024885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isotype class switching and the pathogenesis of multiple myeloma.
    Fenton JA; Pratt G; Rawstron AC; Morgan GJ
    Hematol Oncol; 2002 Jun; 20(2):75-85. PubMed ID: 12111870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.
    Nishida K; Tamura A; Nakazawa N; Ueda Y; Abe T; Matsuda F; Kashima K; Taniwaki M
    Blood; 1997 Jul; 90(2):526-34. PubMed ID: 9226151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent occurrence of CCND1 deregulation in patients with early stages of plasma cell dyscrasia.
    Miura K; Iida S; Hanamura I; Kato M; Banno S; Ishida T; Kusumoto S; Takeuchi G; Miwa H; Nitta M; Inagaki H; Eimoto T; Nomura K; Taniwaki M; Ueda R
    Cancer Sci; 2003 Apr; 94(4):350-4. PubMed ID: 12824903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid amplification of immunoglobulin heavy chain switch (IGHS) translocation breakpoints using long-distance inverse PCR.
    Sonoki T; Willis TG; Oscier DG; Karran EL; Siebert R; Dyer MJ
    Leukemia; 2004 Dec; 18(12):2026-31. PubMed ID: 15496980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.